| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.08 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.07 | 0.2 |